.
MergerLinks Header Logo

Announced

Lilly to acquire Protomer Technologies for c. $1bn.

Financials

Edit Data
Transaction Value£722m
Consideration TypeCash
Capital Owned-
Capital Bid For86%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

United States

Biotechnology

Single Bidder

biotech

Acquisition

Private

Majority

Domestic

Pending

Friendly

Synopsis

Edit

Eli Lilly, a global health care provider, agreed to acquire Protomer Technologies, a private biotech company, for c. $1bn. "Lilly has long strived to make life better for people living with diabetes and we have a continued determination to provide real solutions, including innovation in insulin therapy. Glucose-sensing insulin is the next frontier and has the potential to revolutionize the treatment and quality of life of people with diabetes by dramatically improving both therapeutic efficacy and safety of insulin therapy," Ruth Gimeno, Vice President, Lilly Diabetes Research and Clinical Investigation.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US